Search Results - "Taliansky, A."

Immune checkpoint inhibitors–related encephalitis in melanoma and non-melanoma cancer patients: a single center experience by Taliansky, A., Furman, O., Gadot, M., Urban, D., Bar, J., Shapira-Frumer, R., Kaufman, B., Asher, N., Leibowitz-Amit, R., Itay, A.

“…Background Treatment with immune checkpoint inhibitors (ICI) has greatly improved survival for patients with a number of malignant diseases in recent years…”
Get full text

A RETROSPECTIVE STUDY OF 222 PATIENTS WITH NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA—OUTCOMES INDICATIVE FOR IMPROVED SURVIVAL OVERTIME by Bairey, O., Lebel, E., Buxbaum, C., Porges, T., Taliansky, A., Gurion, R., Goldschmidt, N., Shina, T. Tzuk, Zektser, M., Hofstetter, L., Siegal, T.

Get full text

Validation of a QuECheRS method for analysis of neonicotinoids in small volumes of blood and assessment of exposure in Eurasian eagle owl (Bubo bubo) nestlings by Taliansky-Chamudis, A., Gómez-Ramírez, P., León-Ortega, M., García-Fernández, A.J.

“…Neonicotinoid pesticides have gained great interest in the last years both for agricultural and domestic use. Since the information on their environmental…”
Get full text

P27.13.B INSIGHTS INTO PARANEOPLASTIC NEUROLOGICAL SYNDROMES IN THE ERA OF MODERN ONCOLOGICAL TREATMENTS by Taliansky, A, Zohar, D N

“…Abstract BACKGROUND The paraneoplastic neurological syndromes (PNS) are an uncommon phenomenon with diverse clinical manifestations. The diagnosis of PNS is…”
Get full text

P08.07.B TRANSITION CLINIC IN NEURO-ONCOLOGY WHICH MODEL IS BETTER? THE PATIENT'S OPINION by Azuelos, A, Haisraely, O, Atar, N, Jan, E, Taliansky, A

“…Abstract BACKGROUND The period between adolescence and adulthood is important and complicated for all people. Is much more complicated for young adults (YA)…”
Get full text

P07.03.B THE EFFECT OF SEX HORMONES ON THE COURSE OF MENINGIOMAS IN DIFFERENT HORMONAL PHASES IN THE FEMALE LIFE by Taliansky, A, Haisraely, O, Atar, N, Jan, E, Modan-Moses, D

“…Abstract BACKGROUND The influence of gender on the incidence and the survival of patients with nervous system tumors (NST) is well known, but the mechanism is…”
Get full text

P09.04.B PNES IN BRAIN TUMOR PATIENTS : AN UNEXPECTED CHALLENGE by Loebenstein, R, Eltity, M, Magiel, E, Haisraely, O, Noga, A, Jan, E, Boxer, M, Taliansky, A

“…Abstract BACKGROUND Epileptic seizures (ES) are common in brain tumor patients. The phenomenon of psychogenic non-epileptic seizures (PNES) amongst those…”
Get full text

P11.17.A TEMOZOLOMIDE ONLY FOR GBM MGMT PROMOTER METHYLATEDELDERLY PATIENTS IN REAL CLINICAL SET by Falah, E, Furman, O, Haisraely, O, Atar is, N, Jan, E, Zach, L, Taliansky, A

“…Abstract BACKGROUND The course of glioblastoma (GBM) is worse in elderly and low KPS patients. The NORDIC and NOA08 clinical trials proved the non-inferiority…”
Get full text

P11.18.B AIMING TOWARDS DIFFERENTIATING GLIOBLASTOMA PROGRESSION FROM PSEUDO PROGRESSION -PATIENTS COHORT ESTABLISHMENT AND PRELIMINARY RESULTS by Haisraely, O, Taliansky, A, Kaisman elbaz, T, Abofani, H, Siddeeq, M

“…Abstract BACKGROUND Longitudinal follow-up of glioblastoma patients includes advanced imaging modalities to identify tumor progression, which is of limited…”
Get full text

P14.38 Clinical experience with tumor treating fields (TTFields) treatment for posterior fossa tumors by Taliansky, A, Vagner, T, Jan, E, Zach, L

“…Abstract Introduction: TTFields brought a new concept in the treatment of brain tumors. It was tested and recommended for use in supra-tentorial lesions. There…”
Get full text

P11.67.B A RETROSPECTIVE STUDY OF 222 PATIENTS WITH NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA - OUTCOMES INDICATIVE OF IMPROVED SURVIVAL OVER TIME by Bairey, O, Lebe, E, Buxbaum, C, Porges, T, Taliansky, A, Gurion, R, Goldschmidt, N, Tzuk Shina, T, Zektser, M, Hofstetter, L, Siegal, T

“…Abstract BACKGROUND Primary central nervous system lymphoma (PCNSL) is a rare disease with an incidence of 0.4/per 100,000 person-years. As there is a limited…”
Get full text

Temozolomide treatment for newly diagnosed anaplastic oligodendrogliomas : a clinical efficacy trial by TALIANSKV-ARONOV, A, BOKSTEIN, F, LAVON, I, SIEGAL, T

“…Chemotherapy with alkylating agents is of proven efficacy in recurrent anaplastic oligodendroglioma (AO) with reported response rates ranging between 50% and…”
Get full text

JS1.3 Autoimmune encephalitis as immune related adverse event (irAE) of check point inhibitors (CPI) not so rare as we thought by Taliansky, A, Gadot, M, Urban, D, Bar, J, Shapira-Frumer, R, Kaufman, B, Asher, N, Leibowitz-Amit, R, Itay, A

“…Abstract INTRODUCTION CPI has significant efficacy and toxicities. We describe our experience with CPI treated patients diagnosed with irAE encephalitis…”
Get full text

P05.71 Acute stroke in cancer patients: do they benefit from reperfusion treatment? by Taliansky, A, Bakon, M, Schwammenthal, Y, Mausbach, S, Merzlyak, O, Granbichler, C, Tsabari, R, Chapman, J, Orion, D

“…Abstract Background Thromboembolism is the second leading cause of death in cancer. Stroke is one of thrombotic events that can dramatically change the patient…”
Get full text

GE-04 MGMT METHYLATION IS A POSITIVE PROGNOSTIC MARKER IN PATIENTS WITH ANAPLASTIC ASTROCYTOMA TREATED WITH CONCURRENT TEMOZOLOMIDE AND RADIATION by Blumenthal, D., Bokstein, F., Zelikovitsh, B., Mordechai, A., Lossos, A., Taliansky, A., Zach, L., Tzuk-Shina, T., Lavon, I.

“…BACKGROUND: Concurrent radiation (RT) and temozolomide (TMZ) has been accepted as standard first-line therapy for glioblastoma since publication of results of…”
Get full text

Behavior-based navigation for an indoor mobile robot by Taliansky, A., Shimkin, N.

“…Reports the implementation of a mobile robot system for autonomous indoor navigation. The system architecture is based on a hybrid approach, which combines…”
Get full text

Phenobarbital coma for psychogenic status epilepticus by Taliansky, A, Kramer, U, Neufeld, M Y

“…Among patients seen for epileptic seizures, there is a subgroup of those who do not have epilepsy but suffer from psychogenic paroxysmal events which mimic…”
Get more information